The U.S. Food and Drug Administration has authorized the granting of early access before regulatory approval to Revolution Medicines’ pill for patients with previously treated pancreatic cancer, the company said on Friday. The regulator’s early access program allows patients with serious or life-threatening conditions to receive experimental treatments outside clinical trials before approval. The drug, […] The post FDA Authorizes Early Access to Revolution’s Pancreatic Cancer P...